China’s Sinopharm has sought permission from Pakistan for emergency use of its COVID-19 vaccine in the country.

Sinopharm has applied for registration of its coronavirus vaccine to the Drug Regulatory Authority of Pakistan (DRAP), sources said.

The Chinese vaccine firm has submitted the complete data of the clinical trials of its vaccine to the authority, sources at DRAP said.

A session of the DRAP registration board is expected to be held the next week, the sources at the health ministry said. The registration board will likely to approve the vaccine fore emergency use in Pakistan, sources said.

The approval from the Drug Regulatory Authority will allow the use of the Chinese vaccine in Pakistan, according to sources.